Morgan et al recently pointed out that, while colorectal cancer (CRC) remains a highly
frequent cancer worldwide, trends in CRC incidence are decreasing markedly in some …

Background This study examined repeat colorectal cancer screening rates at 12 and 24
months as part of a randomized intervention trial among Black persons living in the United …

Screening for colorectal cancer (CRC) is cost-effective for reducing its mortality among the
average-risk population. In the US, CRC incidence and mortality differ among racial/ethnic …

Background Colorectal cancer (CRC) is a leading cause of cancer incidence and mortality.
Screening can result in reductions in incidence and mortality, but there are many challenges …

METHODS: In a national mailed survey of 1,800 primary care physicians (PCP) and 600
gastroenterologists, we asked whether physicians would recommend surveillance …

Objectives To inform the development and evaluation of new blood-based colorectal cancer
(CRC) screening tests satisfying minimum United States (US) coverage criteria, we …

Background Markov models are used in health research to simulate health care utilization
and disease states over time. Health phenomena, however, are complex, and the …

Colorectal cancer (CRC) is one of the most prevalent malignancies worldwide, being the
third most commonly diagnosed malignancy and the second leading cause of cancer …

Colorectal cancer (CRC) is a leading cause of mortality in the United States. Outcomes are
greatly improved if CRC is detected early; hence, screening is currently recommended for …

Purpose To assess preferences for design of a pharmacy-based colorectal cancer (CRC)
screening program (PharmFIT™) among screening-eligible adults in the United States (US) …